Similar articles

• HTLV-I infections in French Guiana as monitored by western-blot, dot-blot and PCR techniques.

  Moynet D, Berteau F, Astier-Gin T, Legrand E, Sainte-Foie S, Joly F, Moreau JP, Guillemain B. Moynet D, et al. Leukemia. 1992;6 Suppl 3:106S-109S. Leukemia. 1992. PMID: 1602804 No abstract available.
• Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain.

  Calderón EJ, Gómez-Lucia E, Aguado I, Pineda JA, Essex M, Leal M. Calderón EJ, et al. Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):773-5. doi: 10.1007/BF01972509. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1810736
• Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.

  Brown LS Jr, Chu A, Allain JP, Lee H, Cerney M, Nemoto T. Brown LS Jr, et al. N Y State J Med. 1991 Mar;91(3):93-7. N Y State J Med. 1991. PMID: 2047026
• Human T-cell lymphotropic virus-I in Latin America.

  Gotuzzo E, Arango C, de Queiroz-Campos A, Istúriz RE. Gotuzzo E, et al. Infect Dis Clin North Am. 2000 Mar;14(1):211-39, x-xi. doi: 10.1016/s0891-5520(05)70225-7. Infect Dis Clin North Am. 2000. PMID: 10738680 Review.
• Human T-cell lymphotropic virus type I and II in transfusion medicine.

  Sandler SG, Fang CT, Williams AE. Sandler SG, et al. Transfus Med Rev. 1991 Apr;5(2):93-107. doi: 10.1016/s0887-7963(91)70197-1. Transfus Med Rev. 1991. PMID: 1687974 Review.